FGF23 and nephritis: Compared to untreated Col4α3 knockout mice, the FC-treated mice had decreased serum phosphate concentrations, increased serum iron, dramatically reduced circulating FGF23 levels, decreased markers of systemic and kidney inflammation, improved kidney function, and decreased kidney fibrosis (as evidenced by decreased collagen type I accumulation in the kidney29).